News archive - 2017
- Monday, 7 August 2017
Cellular Therapy for Knee OA
- Friday, 26 May 2017Regeneus Commences Development of Manufacturing Process For Their OA Cellular Therapy. (Japan Chemical Daily Article, May 10, 2017)
- Tuesday, 18 April 2017
Regeneus (ASX:RGS) CEO John Martin will be participating in Austrade’s business delegation to Japan on April 18 and 19 being led by Australia’s minister for trade, tourism and investments.